APOE and Alzheimer disease: Specifically, the AD cases were selected to have relatively early onset (with a minimum age of 65) and a lower frequency of the APOE ε4 allele with the expectation that they were likely to be more enriched for rare high-penetrant AD risk-variants compared to most late-onset AD cases.